Monday, October 18th | 12 Heshvan 5782

Subscribe

avatar Kenneth S. Abramowitz
Kenneth S. Abramowitz is a Managing General Partner and co-founder of NGN Capital, a $250 million worldwide healthcare venture capital fund. He joined NGN from The Carlyle Group in New York where he was Managing Director from 2001 to 2003, focused on U.S. buyout opportunities in the healthcare industry. Prior to joining Carlyle, Mr. Abramowitz worked as an Analyst at Sanford C. Bernstein & Co. where he covered the medical-supply, hospital-management and HMO industries for 23 years. Mr. Abramowitz has published several notable studies on healthcare service companies, major medical mergers and cardiovascular device innovation, among others. Mr. Abramowitz earned a B.A. from Columbia University in 1972 and an M.B.A. from Harvard Business School in 1976. Mr. Abramowitz currently sits on the Board of Directors of EKOS Corp., OptiScan Biomedical Corp., Valtech Ltd., and Small Bone Innovations, Inc.

ARTICLES BY: Kenneth S. Abramowitz


October 25, 2013 5:17 pm
6

15 Reasons Why Iran is an Existential Threat to Western Civilization

1. Iran is the number 1 terror organization in the world today, far more dangerous than Al Qaeda. 2. Iran has largely taken over Syria and...

May 17, 2011 10:29 pm
24

12 Reasons Why Jerusalem Must Remain Under Israeli Control

1. Jerusalem has been the capital city of the Jewish people (but no one else) for 3,000 years, including both ancient Israel and current Israel.  There...

World

Former US Secretary of State Powell Dies of COVID-19 Complications

Colin Powell, the first Black US secretary of state and top military officer, died on Monday at the age of 84 due to complications from COVID-19. He was fully vaccinated,...

Middle East

EU’s Borrell ‘Optimistic’ About Possible New Iran Talks

The European Union's top diplomat Josep Borrell said on Monday he hoped EU and Iranian diplomats would meet soon to discuss a potential return to nuclear talks but declined to...

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.